Sands Capital Alternatives, LLC
25 holdingsFiling period: 2026-06-30Current AUM: $680.6Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ALMR | Alamar Biosciences Inc | 4.23M | $114.6M | $128.6M | 18.89% | -- | 2026-06-30 |
| 2 | — | NU Hldgs Ltd | 7.09M | $94.8M | $94.8M | 13.93% | +557.2K | 2026-06-30 |
| 3 | KVYO | Klaviyo Inc | 3.93M | $59.3M | $81.4M | 11.95% | +278.5K | 2026-06-30 |
| 4 | BBNX | Beta Bionics Inc | 3.71M | $58.1M | $76.1M | 11.17% | -- | 2026-06-30 |
| 5 | SGP | Spyglass Pharma Inc | 2.50M | $55.6M | $74.8M | 10.99% | -- | 2026-06-30 |
| 6 | IKT | Inhibikase Therapeutics Inc | 13.02M | $26.4M | $19.8M | 2.91% | -- | 2026-06-30 |
| 7 | DASH | Doordash Inc | 127.6K | $23.5M | $21.5M | 3.16% | +16.3K | 2026-06-30 |
| 8 | CPNG | Coupang Inc | 1.33M | $23.1M | $18.3M | 2.69% | +317.2K | 2026-06-30 |
| 9 | DDOG | Datadog Inc | 80.9K | $21.1M | $22.7M | 3.33% | -4,942 | 2026-06-30 |
| 10 | BIOA | Bioage Labs Inc | 786.4K | $19.3M | $3.9M | 0.58% | -- | 2026-06-30 |
| 11 | TXG | 10X Genomics Inc | 481.8K | $18.5M | $35.1M | 5.16% | -- | 2026-06-30 |
| 12 | IOT | Samsara Inc | 515.7K | $16.7M | $23.0M | 3.38% | -44,629 | 2026-06-30 |
| 13 | ODTX | Odyssey Therapeutics Inc | 875.0K | $16.4M | $16.9M | 2.48% | -- | 2026-06-30 |
| 14 | TOST | Toast Inc | 364.9K | $10.2M | $11.7M | 1.72% | +63.2K | 2026-06-30 |
| 15 | ABOS | Acumen Pharmaceuticals Inc | 3.72M | $9.9M | $8.4M | 1.24% | -- | 2026-06-30 |
| 16 | TTAN | Servicetitan Inc | 108.5K | $7.7M | $9.0M | 1.33% | +18.7K | 2026-06-30 |
| 17 | CBRS | Cerebras Systems Inc | 32.8K | $7.3M | $3.6M | 0.52% | -- | 2026-06-30 |
| 18 | SNOW | Snowflake Inc | 24.5K | $6.2M | $8.2M | 1.21% | +4.2K | 2026-06-30 |
| 19 | — | Monday.com Ltd | 82.0K | $5.9M | $5.9M | 0.87% | +14.1K | 2026-06-30 |
| 20 | TARS | Tarsus Pharmaceuticals Inc | 85.0K | $5.3M | $6.0M | 0.87% | -- | 2026-06-30 |
| 21 | TSHA | Taysha Gene Therapies Inc | 724.9K | $4.9M | $2.9M | 0.43% | -- | 2026-06-30 |
| 22 | CADL | Candel Therapeutics Inc | 405.8K | $4.2M | $3.2M | 0.46% | -- | 2026-06-30 |
| 23 | ACRV | Acrivon Therapeutics Inc | 2.29M | $4.1M | $3.9M | 0.58% | +166.7K | 2026-06-30 |
| 24 | FIG | Figma Inc | 22.2K | $400K | $520K | 0.08% | +3.9K | 2026-06-30 |
| 25 | FIG | Figma Inc | 22.2K | $400K | $520K | 0.08% | +3.9K | 2026-06-30 |
← Scroll →